Found: 56
Select item for more details and to access through your institution.
Randomized dose-escalation designs for drug combination cancer trials with immunotherapy.
- Published in:
- Journal of Biopharmaceutical Statistics, 2019, v. 29, n. 2, p. 359, doi. 10.1080/10543406.2018.1535503
- By:
- Publication type:
- Article
DOMENICA study (GINECO-EN105b/ENGO-Ten13): randomized phase III trial in MMR deficient (MMRd) endometrial cancer (EC) patients comparing chemotherapy (CT) alone versus dostarlimab in first line advanced/metastatic setting (APGOT-EN1).
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 19, doi. 10.3802/jgo.2024.35.S2.P1
- By:
- Publication type:
- Article
Breast cancer risk in relation to abortion: Results from the EPIC study.
- Published in:
- International Journal of Cancer, 2006, v. 119, n. 7, p. 1741, doi. 10.1002/ijc.22001
- By:
- Publication type:
- Article
Joint modelling of a binary and a continuous outcome measured at two cycles to determine the optimal dose.
- Published in:
- Journal of the Royal Statistical Society: Series C (Applied Statistics), 2019, v. 68, n. 2, p. 369, doi. 10.1111/rssc.12305
- By:
- Publication type:
- Article
Dose finding with longitudinal data: simpler models, richer outcomes.
- Published in:
- Statistics in Medicine, 2015, v. 34, n. 22, p. 2983, doi. 10.1002/sim.6552
- By:
- Publication type:
- Article
Dose-finding design using mixed-effect proportional odds model for longitudinal graded toxicity data in phase I oncology clinical trials.
- Published in:
- Statistics in Medicine, 2013, v. 32, n. 30, p. 5430, doi. 10.1002/sim.5960
- By:
- Publication type:
- Article
Pan‐cancer evaluation of tumor‐infiltrating lymphocytes and programmed cell death protein ligand‐1 in metastatic biopsies and matched primary tumors.
- Published in:
- Journal of Pathology, 2024, v. 264, n. 2, p. 186, doi. 10.1002/path.6334
- By:
- Publication type:
- Article
Multilayer spectrum of intratumoral heterogeneity in basal bladder cancer.
- Published in:
- Journal of Pathology, 2022, v. 256, n. 1, p. 108, doi. 10.1002/path.5813
- By:
- Publication type:
- Article
Quantitative CT Extent of Lung Damage in COVID-19 Pneumonia Is an Independent Risk Factor for Inpatient Mortality in a Population of Cancer Patients: A Prospective Study.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01560
- By:
- Publication type:
- Article
Changing methods to assess targeted therapies in oncology.
- Published in:
- Medical Writing, 2018, v. 27, n. 1, p. 18
- By:
- Publication type:
- Article
Using a new diagnostic tool to predict lymph node metastasis in advanced epithelial ovarian cancer leads to simple lymphadenectomy decision rules: A multicentre study from the FRANCOGYN group.
- Published in:
- PLoS ONE, 2021, v. 16, n. 10, p. 1, doi. 10.1371/journal.pone.0258783
- By:
- Publication type:
- Article
Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program).
- Published in:
- European Heart Journal, 2013, v. 34, n. 2, p. 112, doi. 10.1093/eurheartj/ehs081
- By:
- Publication type:
- Article
An adaptive design for the identification of the optimal dose using joint modeling of continuous repeated biomarker measurements and time-to-toxicity in phase I/II clinical trials in oncology.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A Poisson approach to the validation of failure time surrogate endpoints in individual patient data meta-analyses.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Has tumor doubling time in breast cancer changed over the past 80 years? A systematic review.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 15, p. 5203, doi. 10.1002/cam4.3939
- By:
- Publication type:
- Article
Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 1, p. 109
- By:
- Publication type:
- Article
Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Predictive Gene Signature of Response to the Anti-TweakR mAb PDL192 in Patient-Derived Breast Cancer Xenografts.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0104227
- By:
- Publication type:
- Article
Efficiency of New Dose Escalation Designs in Dose-Finding Phase I Trials of Molecularly Targeted Agents.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0051039
- By:
- Publication type:
- Article
A Meta-Analysis of the Relationship between FGFR3 and TP53 Mutations in Bladder Cancer.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0048993
- By:
- Publication type:
- Article
Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial.
- Published in:
- World Journal of Urology, 2023, v. 41, n. 9, p. 2381, doi. 10.1007/s00345-023-04519-4
- By:
- Publication type:
- Article
Stakeholder Perspectives on Randomized Clinical Trials for Children With Poor-Prognosis Cancers.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 12, p. e2449239, doi. 10.1001/jamanetworkopen.2024.49239
- By:
- Publication type:
- Article
Re: Clinical Characteristics and Outcomes of COVID-19-Infected Cancer Patients: A Systematic Review and Meta-Analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cumulative Toxicity in Targeted Therapies: What to Expect at the Recommended Phase II Dose.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Dissociated Responses in Patients with Metastatic Solid Tumors Treated with Immunotherapy.
- Published in:
- Drugs in R&D, 2021, v. 21, n. 4, p. 399, doi. 10.1007/s40268-021-00362-3
- By:
- Publication type:
- Article
Induced and spontaneous abortion and breast cancer risk: Results from the E3N cohort study.
- Published in:
- International Journal of Cancer, 2003, v. 106, n. 2, p. 270
- By:
- Publication type:
- Article
Utility-Based Optimization of Combination Therapy Using Ordinal Toxicity and Efficacy in Phase I/II Trials.
- Published in:
- Biometrics, 2010, v. 66, n. 2, p. 532, doi. 10.1111/j.1541-0420.2009.01302.x
- By:
- Publication type:
- Article
Continual Reassessment Method for Ordered Groups.
- Published in:
- Biometrics, 2003, v. 59, n. 2, p. 430, doi. 10.1111/1541-0420.00050
- By:
- Publication type:
- Article
Dealing with missing data in the Center for Epidemiologic Studies Depression self-report scale: a study based on the French E3N cohort.
- Published in:
- BMC Medical Research Methodology, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2288-13-28
- By:
- Publication type:
- Article
Dealing with missing data in the Center for Epidemiologic Studies Depression self-report scale: a study based on the French E3N cohort.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Assessment of Progression-Free Survival as a Surrogate End Point of Overall Survival in First-Line Treatment of Ovarian Cancer: A Systematic Review and Meta-analysis.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 1, p. e1918939, doi. 10.1001/jamanetworkopen.2019.18939
- By:
- Publication type:
- Article
Using a dose‐finding benchmark to quantify the loss incurred by dichotomization in Phase II dose‐ranging studies.
- Published in:
- Biometrical Journal, 2020, v. 62, n. 7, p. 1717, doi. 10.1002/bimj.201900332
- By:
- Publication type:
- Article
HANDBOOK OF METHODS FOR DESIGNING, MONITORING, AND ANALYZING DOSE‐FINDING TRIALS.
- Published in:
- Biometrical Journal, 2018, v. 60, n. 5, p. 1024, doi. 10.1002/bimj.201800068
- By:
- Publication type:
- Article
Statistical evaluation of surrogate endpoints with examples from cancer clinical trials.
- Published in:
- Biometrical Journal, 2016, v. 58, n. 1, p. 104, doi. 10.1002/bimj.201400049
- By:
- Publication type:
- Article
Reading, Conducting, and Developing Systematic Review and Individual Patient Data Meta-Analyses in Psychiatry for Treatment Issues.
- Published in:
- Frontiers in Psychiatry, 2021, v. 12, p. 1, doi. 10.3389/fpsyt.2021.644980
- By:
- Publication type:
- Article
Response to comments on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharm Stat 17(5):593‐606, Sep/Oct 2018., DOI:https://doi.org/10.1002/pst.1873
- Published in:
- Pharmaceutical Statistics, 2019, v. 18, n. 3, p. 284, doi. 10.1002/pst.1942
- By:
- Publication type:
- Article
Change‐point joint model for identification of plateau of activity in early phase trials.
- Published in:
- Statistics in Medicine, 2021, v. 40, n. 9, p. 2113, doi. 10.1002/sim.8889
- By:
- Publication type:
- Article
Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 21, p. 1667, doi. 10.1093/jnci/djt269
- By:
- Publication type:
- Article
Disease-Free Survival as a Surrogate for Overall Survival in Adjuvant Trials of Gastric Cancer: A Meta-Analysis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 21, p. 1600, doi. 10.1093/jnci/djt270
- By:
- Publication type:
- Article
Acute and late toxicities of patients infected with SARS-CoV-2 and treated for cancer with radiation therapy during the COVID-19 pandemic.
- Published in:
- International Journal of Radiation Biology, 2021, v. 97, n. 10, p. 1436, doi. 10.1080/09553002.2021.1956008
- By:
- Publication type:
- Article
Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non–muscle-invasive bladder cancer and with low and intermediate EORTC-risk score.
- Published in:
- PLoS ONE, 2019, v. 14, n. 2, p. 1, doi. 10.1371/journal.pone.0211721
- By:
- Publication type:
- Article
Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Optimal Cut Points for Quality of Life Questionnaire-Core 30 (QLQ-C30) Scales: Utility for Clinical Trials and Updates of Prognostic Systems in Advanced Hepatocellular Carcinoma.
- Published in:
- Oncologist, 2015, v. 20, n. 1, p. 62, doi. 10.1634/theoncologist.2014-0175
- By:
- Publication type:
- Article
Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials.
- Published in:
- Quality of Life Research, 2008, v. 17, n. 6, p. 831, doi. 10.1007/s11136-008-9365-y
- By:
- Publication type:
- Article
CA-125 Early Dynamics to Predict Overall Survival in Women with Newly Diagnosed Advanced Ovarian Cancer Based on Meta-Analysis Data.
- Published in:
- Cancers, 2023, v. 15, n. 6, p. 1823, doi. 10.3390/cancers15061823
- By:
- Publication type:
- Article
Time to progression ratio in cancer patients enrolled in early phase clinical trials: time for new guidelines?
- Published in:
- 2018
- By:
- Publication type:
- journal article
Outcome of children with relapsed or refractory neuroblastoma: A meta-analysis of ITCC/SIOPEN European phase II clinical trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A benchmark for dose-finding studies with unknown ordering.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A benchmark for dose finding studies with continuous outcomes.
- Published in:
- 2020
- By:
- Publication type:
- journal article